The US Acquired Hemophilia Treatment Market is witnessing steady growth, driven by increasing awareness of rare bleeding disorders, improvements in diagnostic capabilities, and continuous advancements in treatment options. Acquired hemophilia is a rare autoimmune disorder in which antibodies develop against coagulation factor VIII, resulting in severe and spontaneous bleeding episodes that...